International Journal of Medical Advances and Discoveries
About this Journal
International Journal of Medical Advances and Discovery ISSN 2756-3812 is an international, peer-reviewed, open access journal that welcomes original research articles and reviews of the most current advances and discoveries in life sciences, preclinical and clinical medicine, and related disciplines.
IJMAD is particularly interested in articles that reports significant strides in medical research, disease treatment and the improvement of patients quality of life. In this sense, manuscripts detailing how medical research has transformed healthcare, extending and improving the quality of life for millions, are welcome.
Aims and Scope
To make every effort to contribute to progress in medical sciences so as to bridge laboratory and clinical settings with cutting edge research findings and new developments.
To publish articles which bring novel insights into diagnostic and molecular imaging, offering essential prior knowledge for diagnosis and treatment indispensable in all areas of medical sciences.
To publish articles on pathological sciences giving foundation knowledge on the overall study of human diseases.
To emphasize the significance of pharmaceutical sciences as a rapidly and ever expanding area of research on drug design, development, action and evaluation contributing significantly to a variety of scientific disciplines.
All articles published by this journal are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Also, authors of articles published in this journal are the copyright holders of their articles and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate articles.
International Journal of Medical Advances and Discovery levies an article-processing charge of $500 (USD) for each article accepted for publication. The journal does not charge a submission fee. Authors are required to pay the manuscript handling fee only after their manuscripts have been reviewed and accepted for publication by an editor. Authors can request a waiver or discount during the submission process as the journal routinely waive charges for authors from low-income countries.
ISJ offsets publication expenses – including the cost of peer review management, journal production, and online hosting and archiving – by charging an Article Processing Charge (APC), to authors, institutions or funders for each article published. This publication fees vary by journal and are payable upon article acceptance.
Peer-review is the system used by International Journal of Medical Advances and Discovery to assess the quality of a manuscript before it is published. Qualified researchers in the relevant research area assess submitted manuscripts for originality, validity and significance to help editors determine whether the manuscript should be published or not.
International Journal of Medical Advances and Discovery operates a double-blind peer-review system, where the reviewers of the paper won't get to know the identity of the author(s), and the author(s) won't get to know the identity of the reviewer. The advantage of double-blind peer review is that it eliminates bias.
Manuscripts submitted to this journal will generally be reviewed by two or more experts who will be required to evaluate whether the manuscript is scientifically sound and coherent, whether it duplicates already published work, and whether or not the manuscript is sufficiently clear for publication. The Editors will reach a decision based on these reports and, where necessary, they will consult with members of the Editorial Board.
International Scholars Journals (ISJ) is a member of the Committee on Publication Ethics (COPE) and abides by its Code of Conduct and aims to adhere to its Best Practice Guidelines.
All journals published by ISJ are committed to publishing only innovative and original material i.e., material that has neither been published elsewhere, nor is it under consideration for publication by another publisher.
Benefits of publishing in this journal
At ISJ, we continue to work hard to support our authors who trust us with their works. Here are just some of the benefits we provide:
- Open Access: Our research is freely available to all, from the time of publication. Readers do not need a subscription or to register before they can access our articles.
- High visibility: ISJ allows maximum visibility of articles published in the journal as they are available to the widest possible scientific outreach, including to the general public.
- Rapid publication: The timeframe between acceptance and publication is about 3 weeks. All ISJ journals offer a fast publication schedule.
- Rigorous peer-review: ISJ is operated by a team of experienced professional editors. We work closely with academic editors and reviewers to provide authors with an efficient, fair, and constructive reviews.
- Post-publication comments: ISJ allows readers and authors to exchange ideas that are directly accessible from the full-text article.
- International readership: All articles are being accessed from over 200 countries worldwide.
- Promotion and press coverage: Articles published in this journal are included in article alerts and regular email updates.
- Access and reach: We continue to submit our journals to all known abstracting and indexing services.
- Flexibility: ISJ journals gives you the opportunity to publish at your convenience.
- Copyright: Authors retain the copyright to their works. Authors are allowed unlimited use and/or distribution of their work without any form of restriction. As an author of an article published in any ISJ journal, you retain the copyright of your article and you are free to reproduce and disseminate your work.
To subscribe for an article published by any of our journals, kindly contact email@example.com. The subscription rate is $350 and it is the same for all countries. The subscription charges are inclusive of delivery charges. All journals are open access and subscribers shall receive the print edition.